Skip to Main Content

Paper Details

Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.
N Engl J Med
133
2021
AML, Cancer, Leukemia, MDS, Myeloid Cancers, acute myeloid leukemia, myelodysplastic syndromes, myeloid cancers, patients
Author NameAffiliation
Michelle O'LaughlinMcDonnell Genome Institute (M.O., Washington University School of Medicine
Sharon E HeathMcDonnell Genome Institute (M.O., Washington University School of Medicine
Matthew J ChristopherMcDonnell Genome Institute (M.O., Washington University School of Medicine
Robert S FultonMcDonnell Genome Institute (M.O., Washington University School of Medicine
Robert S FultonMcDonnell Genome Institute (M.O., Washington University School of Medicine
Christopher A MillerMcDonnell Genome Institute (M.O., Washington University School of Medicine
Jacqueline E PaytonMcDonnell Genome Institute (M.O., Washington University School of Medicine
Daniel C LinkMcDonnell Genome Institute (M.O., Washington University School of Medicine
Matthew J WalterMcDonnell Genome Institute (M.O., Washington University School of Medicine
Peter WesterveltMcDonnell Genome Institute (M.O., Washington University School of Medicine
John F DiPersioMcDonnell Genome Institute (M.O., Washington University School of Medicine
Timothy J LeyMcDonnell Genome Institute (M.O., Washington University School of Medicine
David H SpencerMcDonnell Genome Institute (M.O., Washington University School of Medicine
  • 1 - 13

Datasets

Release 1.2